EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0808
0.00 (0.00%)
At close: Oct 21, 2025
EV Biologics Revenue
In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.
Revenue
9.47M
Revenue Growth
-70.48%
P/S Ratio
0.11
Revenue / Employee
n/a
Employees
284
Market Cap
1.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2017 | 9.47M | -32.45K | -0.34% |
| Jun 30, 2017 | 9.51M | -33.14M | -77.71% |
| Jun 30, 2016 | 42.64M | -3.59M | -7.76% |
| Jun 30, 2015 | 46.23M | 1.77M | 3.99% |
| Jun 30, 2014 | 44.46M | 1.98M | 4.65% |
| Jun 30, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
EV Biologics News
- 2 years ago - EV Biologics Updates on Funding and Sales - Accesswire
- 2 years ago - EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic - Accesswire
- 2 years ago - EV Biologics Appoints Senior Investment Banker as Corporate Finance Director - Accesswire
- 2 years ago - EV Biologics Hires Senior Chief Financial Officer - Accesswire
- 2 years ago - EV Biologics Signs Exclusive Distribution Agreement for South America - Accesswire
- 2 years ago - EV Biologics Generates Mesenchymal Stem Cell Lines - Accesswire
- 3 years ago - EV Biologics Updates on Excyte Subsidiary Funding - Accesswire
- 3 years ago - EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX - Accesswire